Related Experiment Video

Updated: Apr 26, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

11.8K

Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer

Aizea Morales-Kastresana1, Sara Labiano1, Ines Gütgemann2

  • 1Departamento de Inmunología; Centro de Investigación Médica Aplicada (CIMA); Universidad de Navarra; Pamplona, Spain.

Oncoimmunology
|July 26, 2014
PubMed

Insights

Combining immunostimulatory monoclonal antibodies can enhance immune responses against tumors. This approach showed synergistic effects in mice with spontaneous cancers, offering a promising strategy for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Monoclonal Antibody Therapy

Background:

  • Immunostimulatory monoclonal antibodies modulate immune system receptors.
  • Combination therapies aim to enhance therapeutic efficacy.
  • Transgenic mouse models are crucial for studying cancer development and treatment.

Purpose of the Study:

  • To investigate the synergistic effects of combined immunostimulatory monoclonal antibodies.
  • To evaluate the therapeutic potential of these combinations in a preclinical cancer model.

Main Methods:

  • Utilized transgenic mice with spontaneous, oncogene-driven tumors.
  • Administered combinations of immunostimulatory monoclonal antibodies.
  • Assessed immune responses and tumor modulation.

Main Results:

  • Demonstrated synergistic elicitation of therapeutically relevant immune responses.
  • Observed efficacy in multifocal hepatocellular carcinomas.
  • Ovalbumin expression served as a surrogate tumor-associated antigen.

Conclusions:

  • Combination immunotherapy with immunostimulatory monoclonal antibodies shows significant promise.
  • This strategy can synergistically enhance anti-tumor immune responses.
  • Preclinical models support the development of such combinations for cancer treatment.
Keywords:
B7-H1 (PD-L1)CD137 (4-1BB)OX40 (CD134)T lymphocytesimmunotherapy

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K